Tag: international

Neftaly is a Global Solutions Provider working with Individuals, Governments, Corporate Businesses, Municipalities, International Institutions. Neftaly works across various Industries, Sectors providing wide range of solutions.

Neftaly Email: info@neftaly.net Call/WhatsApp: + 27 84 313 7407

  • Neftaly Role of international organizations in influencing biomarker policy

    Neftaly Role of international organizations in influencing biomarker policy

    Role of International Organizations in Influencing Biomarker Policy

    Biomarkers have emerged as critical tools in advancing precision medicine, early diagnosis, and improved patient outcomes globally. The development and implementation of effective biomarker policies, however, require coordination, guidance, and support that transcend national boundaries. This is where international organizations play a pivotal role.

    At Neftaly, we recognize that international organizations are instrumental in shaping biomarker policies by providing technical expertise, fostering collaboration, and promoting standards that ensure equitable access and ethical use.


    Key Contributions of International Organizations

    1. Setting Global Standards and Guidelines

    • Organizations like the World Health Organization (WHO) and the International Council for Harmonisation (ICH) develop evidence-based guidelines for biomarker validation, clinical use, and regulatory approval.
    • These standards promote consistency and quality assurance, enabling countries to align their policies with international best practices.

    2. Providing Technical Assistance and Capacity Building

    • International bodies offer training, resources, and technical support to strengthen national capacities in biomarker research, regulation, and implementation.
    • Programs facilitated by organizations such as the Global Fund, Gavi, and UNICEF often include components that support biomarker integration into disease control strategies.

    3. Facilitating Research Collaboration and Data Sharing

    • Platforms coordinated by entities like the Coalition for Epidemic Preparedness Innovations (CEPI) and the Global Alliance for Genomics and Health (GA4GH) foster global collaboration on biomarker research.
    • Sharing data and best practices accelerates innovation and informs policy development based on diverse populations and contexts.

    4. Advocating for Equity and Access

    • International organizations emphasize reducing health disparities by advocating for the inclusion of biomarker technologies in essential diagnostics lists and universal health coverage schemes.
    • They work to ensure marginalized and low-resource settings benefit from biomarker advancements.

    5. Mobilizing Funding and Resources

    • Many international organizations manage or influence global financing mechanisms that support biomarker research, validation, and deployment.
    • Their advocacy efforts help channel investments toward sustainable biomarker policies and health system integration.

    Challenges and Opportunities

    • Challenges: Variability in national regulatory frameworks, limited infrastructure in low-income settings, and ethical considerations around data privacy.
    • Opportunities: Strengthening global partnerships, harmonizing regulatory pathways, and leveraging digital health innovations to scale biomarker use.

    Conclusion

    International organizations play a crucial role in shaping biomarker policy by providing the frameworks, knowledge, and resources needed to translate scientific advances into health gains worldwide. Neftaly supports leveraging these global partnerships to promote biomarker policies that are effective, equitable, and sustainable.

  • Neftaly Role of international collaborations in technology transfer

    Neftaly Role of international collaborations in technology transfer

    Neftaly: The Role of International Collaborations in Technology Transfer

    Technology transfer plays a crucial role in bridging the gap between innovation and application—especially in the fields of public health and biomarker science. At Neftaly, we believe that international collaboration is essential for accelerating the responsible and equitable transfer of technologies, particularly to regions where the health burden is high and access to innovation is limited.


    Why International Collaboration Is Essential

    Technology transfer is most effective when it is grounded in shared knowledge, mutual trust, and aligned objectives across borders. International partnerships contribute to:

    • Faster adoption of new diagnostics, treatments, and surveillance tools
    • Broader access to cutting-edge health technologies
    • Capacity building in low- and middle-income countries
    • Greater innovation through cross-disciplinary, cross-cultural exchange
    • Harmonized standards for regulatory approval and data use

    Key Areas Where Collaboration Enhances Technology Transfer

    1. Joint Research and Development (R&D)

    Neftaly facilitates partnerships between global research institutions and local innovators to co-develop and adapt biomarker technologies suited to different settings.

    2. Shared Infrastructure and Resources

    Collaborations allow for the sharing of laboratory facilities, testing platforms, and biorepositories, reducing duplication and enhancing efficiency.

    3. Technical and Scientific Exchange

    International training programs, fellowships, and knowledge-sharing platforms promote skill development and empower local researchers and health professionals.

    4. Regulatory Alignment and Policy Development

    Global cooperation helps harmonize regulatory pathways for technology approval, ensuring smoother integration into health systems.

    5. Ethical and Equitable Access

    Collaborations based on equity promote fair licensing, transparent data use, and inclusive benefit-sharing, ensuring that health innovations reach underserved populations.


    Neftaly’s Role in Facilitating International Collaborations

    • Brokering Strategic Partnerships: Neftaly connects governments, academic institutions, NGOs, and private sector actors to build shared innovation pipelines.
    • Supporting Cross-Border Projects: We coordinate international pilot programs to test and scale biomarker technologies in real-world, diverse environments.
    • Promoting South–South and North–South Cooperation: We facilitate peer learning and capacity-sharing between countries with complementary strengths and needs.
    • Providing Legal and Technical Guidance: Neftaly helps navigate intellectual property rights, technology licensing, and local adaptation challenges.
    • Co-hosting Global Forums: We bring together international stakeholders for dialogue, planning, and problem-solving around shared health goals.

    Real-World Impact

    In one Neftaly-led initiative, a collaboration between a European diagnostic developer and an African public health institute resulted in the successful localization of a biomarker-based TB diagnostic. This partnership led to:

    • Reduced diagnostic costs
    • Faster uptake into national health systems
    • Local workforce training and lab capacity upgrades
    • Improved detection rates in high-burden communities

    Conclusion

    International collaboration is the backbone of impactful and sustainable technology transfer. By breaking down borders and building bridges between institutions, Neftaly helps ensure that scientific advancements benefit all—not just those in high-resource settings. Through global partnerships, we are not just transferring technologies—we are co-creating health solutions that are inclusive, scalable, and equitable.